KERA Antikörper (AA 253-351)
Kurzübersicht für KERA Antikörper (AA 253-351) (ABIN564810)
Target
Alle KERA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 253-351
-
Verwendungszweck
- Mouse polyclonal antibody raised against a partial recombinant KERA.
-
Sequenz
- GLPSRGFDVS SILDLQLSHN QLTKVPRISA HLQHLHLDHN KIKSVNVSVI CPSPSMLPAE RDSFSYGPHL RYLRLDGNEI KPPIPMALMT CFRLLQAVI
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
-
Immunogen
- KERA (NP_008966, 253 a.a. ~ 351 a.a) partial recombinant protein with GST tag.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 50 % glycerol
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
-
Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases." in: Investigative ophthalmology & visual science, Vol. 54, Issue 2, pp. 1014-25, (2013) (PubMed).
: "Effects of ultraviolet-A and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking." in: The Journal of biological chemistry, Vol. 286, Issue 15, pp. 13011-22, (2011) (PubMed).
: "
-
Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases." in: Investigative ophthalmology & visual science, Vol. 54, Issue 2, pp. 1014-25, (2013) (PubMed).
-
- KERA (Keratocan (KERA))
-
Andere Bezeichnung
- KERA
-
Hintergrund
-
Full Gene Name: keratocan
Synonyms: CNA2,SLRR2B -
Gen-ID
- 11081
-
NCBI Accession
- NM_007035
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-